115 results
Page 6 of 6
6-K
EX-99.1
hrb1lv
3 Jun 19
Zai Lab Appoints Valeria Fantin, Ph.D., as Chief Scientific Officer
7:31am
424B2
yna7mo6bsn
6 May 19
Prospectus for primary offering
6:04am
424B5
7eymmbro ja48s
1 May 19
Prospectus supplement for primary offering
5:26pm
6-K
EX-99.1
ysjxxb
12 Dec 18
Zai Lab Announces Acceptance of NDA Submission of ZEJULA (Niraparib) in Mainland China by the NMPA
7:35am
6-K
9aeacpv5vpyeas5k
30 Nov 18
Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing development
6:06am
6-K
EX-99.1
od73u
30 Nov 18
Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing development
6:06am
6-K
EX-99.1
x6f2c
22 Oct 18
Zai Lab Announces Approval of ZEJULA® (Niraparib) for Patients with Relapsed Ovarian Cancer in Hong Kong
7:48am
424B4
8985niebhe1gjy00h9s4
7 Sep 18
Prospectus supplement with pricing info
12:00am
6-K
EX-99.1
9y97c
14 Aug 18
Zai Lab Appoints Professor Kai-Xian Chen, Ph.D., to its Board of Directors
7:36am
20-F
EX-4.11
tx98cs1giwf52hbw92a
30 Apr 18
Annual report (foreign)
9:07am
20-F
xe4p3vsl3rjb6iewg9h
30 Apr 18
Annual report (foreign)
9:07am
6-K
EX-99.1
aw06g1o uuuxm4
25 Apr 18
Global Strategic Development Collaboration for ETX2514
12:00am